Skip to main content

Table 1 Clinicopathological characteristic of 412 patients with BCa from TCGA database

From: Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis

Clinicopathological characteristics

Value

Age, years

 Mean ± SD

68.09 ± 10.58

 Range

34–90

Gender, n (%)

 Female

108 (26.2)

 Male

304 (73.8)

Grade, n (%)

 High

388 (94.1)

 Low

21 (5.1)

 Unknown

3 (0.8)

TCGA stage

 Stage I

2 (0.5)

 Stage II

131 (31.8)

 Stage III

141 (34.2)

 Stage IV

136 (33.0)

 Unknown

2 (0.5)

T stage, n (%)

 T0

1 (0.2)

 T1

3 (0.7)

 T2

120 (29.1)

 T3

196 (47.6)

 T4

59 (14.3)

 Unknown

33 (8.1)

N stage, n (%)

 N0

239 (58.1)

 N1

47 (11.4)

 N2

76 (18.4)

 N3

8 (1.9)

 Unknown

42 (10.2)

M stage, n (%)

 M0

196 (47.5)

 M1

11 (2.7)

 Unknown

205 (49.8)